SY
So-Young International Inc.
Price Chart
Latest Quote
$2.10
-0.02 (-0.94%)
Current Price
| Previous Close | $2.12 |
| Open | $2.10 |
| Day High | $2.13 |
| Day Low | $2.10 |
| Volume | 54,986 |
Stock Information
Note: Financial values converted from CNY to USD
| Shares Outstanding | 85.01M |
| Total Debt | $57.16M |
| Cash Equivalents | $119.81M |
| Revenue | $249.24M |
| Net Income | $-38.81M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $211.29M |
| EPS (TTM) | $-0.35 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-89.76M |
| Sales | $249.24M |
| Income | $-38.81M |
| Book/sh | $2.23 |
| Cash/sh | $9.38 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.00 |
| Current Ratio | 1.73 |
| Debt/Eq | 23.65 |
Returns & Margins
| ROA | -6.61% |
| ROE | -15.04% |
| Gross Margin | 46.03% |
| Operating Margin | -13.38% |
| Profit Margin | -15.57% |
Ownership
| Insider Ownership | 21.86% |
| Institutional Ownership | 19.33% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -28.89 |
| P/S | 0.13 |
| P/B | 0.94 |
Analyst Data
| Recommendation | none |
| Target Price | $7.36 |
Technical Indicators
| SMA20 | $2.42 |
| SMA50 | $2.54 |
| SMA200 | $2.53 |
| RSI | 22.89 |
| ATR | 0.1016 |
| Shares Float | 52.99M |
| Short Float | 1.94% |
| Short Ratio | 0.90 |
| Volatility | 2.05 |
| Rel Volume | 0.23 |
Performance History
| Week | -7.08% |
| Month | -21.93% |
| Quarter | +8.25% |
| 6 Months | -26.57% |
| YTD | -21.35% |
| Year | -29.53% |
| 3 Years | +155.59% |
| 5 Years | -48.13% |
| 10 Years | -87.40% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $2.10 | 54,986 |
| 2026-10-26 | $2.12 | 116,700 |
| 2026-10-23 | $2.11 | 139,200 |
| 2026-10-22 | $2.13 | 266,500 |
| 2026-10-21 | $2.19 | 165,800 |
| 2026-10-20 | $2.26 | 78,000 |
| 2026-10-19 | $2.25 | 98,500 |
| 2026-10-16 | $2.27 | 647,400 |
| 2026-10-15 | $2.34 | 319,200 |
| 2026-10-14 | $2.45 | 228,200 |
| 2026-10-13 | $2.65 | 98,300 |
| 2026-10-12 | $2.56 | 406,300 |
| 2026-10-09 | $2.49 | 94,300 |
| 2026-10-08 | $2.48 | 99,500 |
| 2026-10-07 | $2.55 | 416,300 |
| 2026-10-06 | $2.57 | 300,300 |
| 2026-10-05 | $2.74 | 481,800 |
| 2026-10-02 | $2.75 | 232,600 |
| 2026-10-01 | $2.70 | 242,500 |
| 2026-09-30 | $2.67 | 355,900 |
| 2026-09-29 | $2.71 | 293,800 |
| 2026-09-28 | $2.69 | 203,700 |
About So-Young International Inc.
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical aesthetic institutions; Weixin mini program to explore treatment options, check prices, schedule appointments, participate in online consultations, and track follow-ups; and medical aesthetic community content through its website soyoung.com. Its aesthetic centers offer non-invasive to minimally invasive procedures, including device-based options, such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, and body contouring treatments, as well as injectable treatments, including skin boosters, hyaluronic acid-based products, botox, and type I and type III collagen. In addition, the company engages in the research and development, production, sale, and distribution of light therapy devices, including excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, and advanced laser and intense pulsed light technologies; surgical laser devices, including carbon dioxide laser machines, multi-wavelength and semiconductor laser systems for urological treatments, and hydrodynamic-assisted liposuction systems for plastic surgery, as well as pneumatic liquid spray devices skin cleansing. Further, it offers injectable products; sales and technical, maintenance, installation, operational training, error reporting, maintenance, and equipment packaging services; consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and content management through beauty diaries, short-form videos, treatment reviews, featured articles, and chat messages. The company was founded in 2013 and is headquartered in Beijing, China.
đ° Latest News
No news articles available at the moment. Check back later for updates on SY.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $119,100,596 | $84,953,824 | $81,474,008 | $58,866,354 |
| Cost Of Revenue | $119,100,596 | $84,953,824 | $81,474,008 | $58,866,354 |
| Total Revenue | $228,017,839 | $219,529,417 | $224,218,914 | $188,273,486 |
| Operating Revenue | $228,017,839 | $219,529,417 | $224,218,914 | $188,273,486 |
| Expenses | ||||
| Total Expenses | $267,901,540 | $232,174,490 | $233,356,181 | $203,660,922 |
| Other Income Expense | $-478,664 | $-82,338,387 | $3,004,445 | $-1,968,239 |
| Other Non Operating Income Expenses | $1,931,119 | $169,283 | $3,277,604 | $1,234,228 |
| Net Non Operating Interest Income Expense | $3,525,767 | $6,960,979 | $7,310,622 | $4,323,090 |
| Operating Expense | $148,800,944 | $147,220,666 | $151,882,174 | $144,794,568 |
| Selling And Marketing Expense | $79,117,360 | $74,013,710 | $77,898,998 | $70,660,819 |
| General And Administrative Expense | $49,171,992 | $48,505,934 | $43,520,528 | $38,946,880 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-36,266,632 | $-88,238,014 | $3,185,104 | $-9,811,857 |
| Net Interest Income | $3,525,767 | $6,960,979 | $7,310,622 | $4,323,090 |
| Interest Income | $3,525,767 | $6,960,979 | $7,310,622 | $4,323,090 |
| Normalized Income | $-34,916,855 | $-8,101,240 | $1,961,728 | $-9,337,649 |
| Net Income From Continuing And Discontinued Operation | $-36,266,632 | $-88,238,014 | $3,185,104 | $-9,811,857 |
| Total Operating Income As Reported | $-42,833,814 | $-93,471,433 | $-9,137,268 | $-15,387,436 |
| Net Income Common Stockholders | $-36,266,632 | $-88,238,014 | $3,185,104 | $-9,811,857 |
| Net Income | $-36,266,632 | $-88,238,014 | $3,185,104 | $-9,811,857 |
| Net Income Including Noncontrolling Interests | $-36,955,740 | $-87,887,024 | $3,883,193 | $-9,894,628 |
| Net Income Continuous Operations | $-36,955,740 | $-87,887,024 | $3,883,193 | $-9,894,628 |
| Pretax Income | $-36,836,598 | $-88,022,480 | $1,177,800 | $-13,032,584 |
| Special Income Charges | $-2,950,113 | $-81,926,478 | $-66,456 | $-1,189,175 |
| Earnings From Equity Interest | $-610,079 | $-2,247,384 | $-1,904,327 | $-2,577,869 |
| Interest Income Non Operating | $3,525,767 | $6,960,979 | $7,310,622 | $4,323,090 |
| Operating Income | $-39,883,701 | $-12,645,073 | $-9,137,268 | $-15,387,436 |
| Gross Profit | $108,917,243 | $134,575,592 | $142,744,906 | $129,407,132 |
| Per Share | ||||
| Diluted EPS | $-0.36 | $-0.86 | $0.03 | $-0.09 |
| Basic EPS | $-0.36 | $-0.86 | $0.03 | $-0.09 |
| Other | ||||
| Tax Effect Of Unusual Items | $-449,926 | $-123,512 | $407,792 | $-150,389 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-29,520,737 | $74,488,033 | $-3,869,872 | $-7,715,197 |
| Total Unusual Items | $-1,799,704 | $-80,260,286 | $1,631,169 | $-624,598 |
| Total Unusual Items Excluding Goodwill | $-1,799,704 | $-80,260,286 | $1,631,169 | $-624,598 |
| Reconciled Depreciation | $8,563,260 | $6,872,820 | $6,898,565 | $7,047,642 |
| EBITDA (Bullshit earnings) | $-31,320,441 | $-5,772,253 | $-2,238,703 | $-8,339,794 |
| EBIT | $-39,883,701 | $-12,645,073 | $-9,137,268 | $-15,387,436 |
| Diluted Average Shares | $15,150,620 | $15,446,527 | $15,187,833 | $16,084,904 |
| Basic Average Shares | $15,150,620 | $15,446,527 | $15,108,435 | $16,084,904 |
| Diluted NI Availto Com Stockholders | $-36,266,632 | $-88,238,014 | $3,185,104 | $-9,811,857 |
| Minority Interests | $689,108 | $-350,990 | $-698,089 | $82,771 |
| Tax Provision | $119,142 | $-135,457 | $-2,705,393 | $-3,137,956 |
| Write Off | $0 | $1,100,118 | $66,456 | $1,189,175 |
| Impairment Of Capital Assets | $2,950,113 | $80,826,360 | $0 | $0 |
| Gain On Sale Of Security | $1,150,409 | $1,666,193 | $1,697,625 | $564,578 |
| Research And Development | $20,511,592 | $24,701,022 | $30,462,648 | $35,186,870 |
| Selling General And Administration | $128,289,352 | $122,519,644 | $121,419,525 | $109,607,698 |
| Other Gand A | $49,171,992 | $48,505,934 | $43,520,528 | $38,946,880 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-10-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $210,823,665 | $256,218,584 | $263,157,711 | $267,613,414 |
| Total Assets | $396,586,785 | $409,387,372 | $481,143,070 | $478,644,679 |
| Total Non Current Assets | $174,378,469 | $151,292,151 | $223,412,460 | $191,741,777 |
| Other Non Current Assets | $72,144 | $667,854 | $1,787,580 | $512,790 |
| Non Current Prepaid Assets | $9,441,260 | $18,609,959 | $24,318,899 | $2,150,843 |
| Non Current Deferred Assets | $10,374,489 | $12,714,972 | $11,679,813 | $9,689,871 |
| Non Current Deferred Taxes Assets | $10,374,489 | $12,714,972 | $11,679,813 | $9,689,871 |
| Non Current Note Receivables | $10,093,847 | $10,680,127 | $8,686,444 | $12,198,141 |
| Goodwill And Other Intangible Assets | $21,670,234 | $19,053,599 | $102,669,619 | $106,265,883 |
| Other Intangible Assets | $21,567,855 | $18,951,220 | $21,740,881 | $25,337,145 |
| Current Assets | $222,208,317 | $258,095,221 | $257,730,611 | $286,902,902 |
| Other Current Assets | $1,399,769 | $1,487,330 | $902,097 | $356,528 |
| Restricted Cash | $9,681,489 | $9,933,544 | $2,199,488 | $2,231,369 |
| Prepaid Assets | $14,306,776 | $12,461,870 | $8,165,721 | $5,746,658 |
| Inventory | $34,932,720 | $22,713,924 | $17,800,063 | $18,032,958 |
| Receivables | $31,417,281 | $33,864,633 | $30,051,937 | $25,488,018 |
| Other Receivables | $2,439,119 | $3,630,390 | $3,466,196 | $2,213,258 |
| Taxes Receivable | $7,269,162 | $1,974,525 | $1,575,190 | $802,562 |
| Accrued Interest Receivable | $1,820,658 | $2,464,115 | $3,133,915 | $2,217,300 |
| Loans Receivable | $12,059,391 | $10,829,205 | $11,933,514 | $9,869,183 |
| Accounts Receivable | $7,713,101 | $14,784,092 | $8,564,308 | $5,389,232 |
| Allowance For Doubtful Accounts Receivable | $-19,563,395 | $-16,376,644 | $-2,339,285 | $-1,979,315 |
| Gross Accounts Receivable | $27,276,496 | $31,160,737 | $10,903,594 | $7,368,547 |
| Cash Cash Equivalents And Short Term Investments | $130,470,280 | $177,633,921 | $198,611,304 | $235,047,370 |
| Cash And Cash Equivalents | $62,596,428 | $87,971,890 | $63,779,766 | $103,937,973 |
| Debt | ||||
| Total Debt | $44,859,978 | $35,903,668 | $21,818,862 | $10,665,459 |
| Long Term Debt And Capital Lease Obligation | $27,445,181 | $18,739,429 | $12,903,564 | $3,139,004 |
| Current Debt And Capital Lease Obligation | $17,414,797 | $17,164,239 | $8,915,298 | $7,526,455 |
| Current Debt | $5,959,198 | $10,443,041 | $4,464,085 | - |
| Other Current Borrowings | $5,959,198 | $10,443,041 | $4,464,085 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $146,804,567 | $116,212,599 | $97,775,964 | $88,309,559 |
| Total Non Current Liabilities Net Minority Interest | $29,450,539 | $21,885,917 | $16,887,638 | $7,777,911 |
| Other Non Current Liabilities | $416,548 | $189,190 | $229,902 | - |
| Non Current Deferred Liabilities | $1,588,810 | $2,957,297 | $3,754,172 | $4,638,907 |
| Non Current Deferred Taxes Liabilities | $1,588,810 | $2,957,297 | $3,754,172 | $4,638,907 |
| Current Liabilities | $117,354,027 | $94,326,682 | $80,888,326 | $80,531,648 |
| Other Current Liabilities | $4,517,070 | $2,747,302 | $1,596,743 | $1,711,095 |
| Current Deferred Liabilities | $43,801,918 | $28,493,212 | $29,218,691 | $27,192,079 |
| Payables And Accrued Expenses | $51,620,242 | $45,921,929 | $41,157,593 | $44,102,019 |
| Payables | $43,278,651 | $38,694,376 | $33,559,144 | $36,176,228 |
| Other Payable | $36,681,085 | $29,363,727 | $24,985,406 | $24,131,056 |
| Total Tax Payable | $6,505,066 | $9,259,254 | $8,515,663 | $11,162,832 |
| Income Tax Payable | $1,678,466 | $3,896,514 | $3,718,998 | $5,766,715 |
| Equity | ||||
| Common Stock Equity | $232,493,898 | $275,272,183 | $365,827,330 | $373,879,297 |
| Total Equity Gross Minority Interest | $249,782,219 | $293,174,774 | $383,367,106 | $390,335,120 |
| Stockholders Equity | $232,493,898 | $275,272,183 | $365,827,330 | $373,879,297 |
| Gains Losses Not Affecting Retained Earnings | $8,948,826 | $10,793,432 | $7,789,136 | $4,959,363 |
| Other Equity Adjustments | $8,948,826 | $10,793,432 | $7,789,136 | $4,959,363 |
| Retained Earnings | $-175,807,425 | $-138,658,303 | $-49,417,910 | $-51,880,378 |
| Other | ||||
| Treasury Shares Number | $2,084,586 | $1,831,803 | $1,536,515 | $632,032 |
| Ordinary Shares Number | $11,538,441 | $11,623,761 | $11,288,925 | $12,100,301 |
| Share Issued | $13,623,027 | $13,455,564 | $12,825,439 | $12,732,332 |
| Tangible Book Value | $210,823,665 | $256,218,584 | $263,157,711 | $267,613,414 |
| Invested Capital | $238,453,097 | $285,715,224 | $370,291,415 | $373,879,297 |
| Working Capital | $104,854,289 | $163,768,539 | $176,842,285 | $206,371,254 |
| Capital Lease Obligations | $38,900,779 | $25,460,627 | $17,354,777 | $10,665,459 |
| Total Capitalization | $232,493,898 | $275,272,183 | $365,827,330 | $373,879,297 |
| Minority Interest | $17,288,321 | $17,902,591 | $17,539,776 | $16,455,823 |
| Treasury Stock | $58,664,591 | $56,381,434 | $53,651,793 | $34,849,800 |
| Additional Paid In Capital | $457,973,083 | $459,475,082 | $461,066,736 | $455,609,251 |
| Capital Stock | $44,005 | $43,406 | $41,161 | $40,862 |
| Common Stock | $44,005 | $43,406 | $41,161 | $40,862 |
| Long Term Capital Lease Obligation | $27,445,181 | $18,739,429 | $12,903,564 | $3,139,004 |
| Current Deferred Revenue | $43,801,918 | $28,493,212 | $29,218,691 | $27,192,079 |
| Current Capital Lease Obligation | $11,455,599 | $6,721,199 | $4,451,213 | $7,526,455 |
| Current Accrued Expenses | $8,341,590 | $7,227,552 | $7,598,449 | $7,925,791 |
| Dueto Related Parties Current | $92,500 | $71,395 | $58,074 | $882,340 |
| Investments And Advances | $41,123,916 | $41,951,325 | $39,067,818 | $34,119,980 |
| Goodwill | $102,378 | $102,378 | $80,928,738 | $80,928,738 |
| Net PPE | $81,602,580 | $47,614,315 | $35,202,287 | $26,804,268 |
| Accumulated Depreciation | $-19,597,521 | $-13,992,456 | $-10,824,265 | $-7,980,422 |
| Gross PPE | $101,200,101 | $61,606,771 | $46,026,552 | $34,784,691 |
| Leases | $19,076,948 | $11,117,331 | $4,909,970 | $4,892,158 |
| Other Properties | $63,252,607 | $32,102,049 | $22,970,768 | $2,480,280 |
| Machinery Furniture Equipment | $4,027,780 | $3,544,626 | $3,303,049 | $3,155,169 |
| Buildings And Improvements | $14,842,765 | $14,842,765 | $14,842,765 | $24,257,083 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $25,770,307 | $14,141,683 | $8,696,622 | $12,152,190 |
| Raw Materials | $9,162,413 | $8,572,241 | $9,103,441 | $8,541,408 |
| Duefrom Related Parties Current | $115,849 | $182,305 | $1,378,815 | $4,996,483 |
| Other Short Term Investments | $67,873,852 | $89,662,031 | $134,831,538 | $131,109,397 |
| Inventories Adjustments Allowances | - | - | $-2,550,778 | $-2,660,640 |
Fetched: 2026-10-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-45,203,484 | $-13,198,575 | $-4,291,958 | $-19,245,334 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,774,498 | $-3,836,644 | $3,367,859 | $-16,894,374 |
| Cash Flow From Continuing Operating Activities | $-15,774,498 | $-3,836,644 | $3,367,859 | $-16,894,374 |
| Operating Gains Losses | $448,728 | $2,223,885 | $1,230,935 | $2,659,592 |
| Investing Activities | ||||
| Capital Expenditure | $-29,428,986 | $-9,361,931 | $-7,659,816 | $-2,350,960 |
| Investing Cash Flow | $-6,407,178 | $38,472,557 | $-30,325,994 | $-85,646,375 |
| Cash Flow From Continuing Investing Activities | $-6,407,178 | $38,472,557 | $-30,325,994 | $-85,646,375 |
| Net Other Investing Changes | $74,838 | $1,104,010 | $1,540,166 | $-2,713,625 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-2,283,157 | $-2,729,640 | $-18,801,993 | $-2,263,549 |
| Financing Cash Flow | $-9,534,807 | $-3,219,829 | $-14,969,840 | $-2,033,497 |
| Cash Flow From Continuing Financing Activities | $-9,534,807 | $-3,219,829 | $-14,969,840 | $-2,033,497 |
| Net Other Financing Charges | $74,838 | - | $-660,670 | $98,936 |
| Cash Dividends Paid | $-2,848,034 | $-6,521,830 | $0 | $0 |
| Common Stock Dividend Paid | $-2,848,034 | $-6,521,830 | $0 | $0 |
| Net Common Stock Issuance | $-2,283,157 | $-2,729,640 | $-18,801,993 | $-2,263,549 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-19,457,874 | $-10,477,316 | $0 | $0 |
| Issuance Of Debt | $14,967,595 | $16,464,354 | $4,464,085 | $0 |
| Income Tax Paid Supplemental Data | $1,462,035 | $1,736,091 | $2,433,282 | $1,700,319 |
| End Cash Position | $64,748,020 | $96,686,024 | $64,770,771 | $104,922,841 |
| Beginning Cash Position | $96,686,024 | $64,770,771 | $104,922,841 | $201,135,889 |
| Effect Of Exchange Rate Changes | $-221,520 | $499,169 | $1,775,905 | $8,361,198 |
| Changes In Cash | $-31,716,483 | $31,416,084 | $-41,927,975 | $-104,574,246 |
| Proceeds From Stock Option Exercised | $11,824 | $44,603 | $28,738 | $131,116 |
| Common Stock Payments | $-2,283,157 | $-2,729,640 | $-18,801,993 | $-2,263,549 |
| Net Issuance Payments Of Debt | $-4,490,278 | $5,987,038 | $4,464,085 | $0 |
| Net Short Term Debt Issuance | $-4,490,278 | $5,987,038 | $4,464,085 | $0 |
| Short Term Debt Payments | $-19,457,874 | $-10,477,316 | $0 | $0 |
| Short Term Debt Issuance | $14,967,595 | $16,464,354 | $4,464,085 | $0 |
| Net Investment Purchase And Sale | $22,946,970 | $46,210,055 | $-25,234,467 | $-66,004,849 |
| Sale Of Investment | $153,507,056 | $228,571,640 | $314,782,443 | $114,469,921 |
| Purchase Of Investment | $-130,560,086 | $-182,361,585 | $-340,016,910 | $-180,474,770 |
| Net Business Purchase And Sale | $0 | $508,898 | $983,371 | $-14,592,208 |
| Sale Of Business | $0 | $508,898 | $983,371 | $0 |
| Net PPE Purchase And Sale | $-29,428,986 | $-9,350,406 | $-7,615,063 | $-2,335,693 |
| Sale Of PPE | $0 | $11,525 | $44,753 | $15,267 |
| Purchase Of PPE | $-29,428,986 | $-9,361,931 | $-7,659,816 | $-2,350,960 |
| Change In Working Capital | $-3,908,338 | $-25,123,408 | $-18,327,072 | $-29,186,960 |
| Change In Other Working Capital | $-1,349,478 | $-3,996,348 | $-1,872,895 | $-3,756,567 |
| Change In Other Current Liabilities | $-8,499,798 | $-5,685,291 | $-8,459,236 | $-6,062,624 |
| Change In Other Current Assets | $-528,955 | $-4,481,298 | $850,459 | $-7,684,363 |
| Change In Payables And Accrued Expense | $26,228,315 | $9,860,203 | $4,609,421 | $-2,911,497 |
| Change In Accrued Expense | $23,134,065 | $4,185,089 | $2,718,864 | $-2,335,394 |
| Change In Payable | $3,094,251 | $5,675,113 | $1,890,557 | $-576,103 |
| Change In Tax Payable | $284,235 | $1,917,349 | $-243,972 | $4,077,622 |
| Change In Income Tax Payable | $284,235 | $1,917,349 | $-243,972 | $4,077,622 |
| Change In Prepaid Assets | $-6,848,124 | $-6,118,154 | $-7,551,152 | $-7,223,212 |
| Change In Inventory | $-17,359,267 | $-5,500,741 | $-317,612 | $-4,189,130 |
| Change In Receivables | $4,448,968 | $-9,201,778 | $-5,586,056 | $2,640,433 |
| Changes In Account Receivables | $3,257,697 | $-9,037,584 | $-4,333,119 | $2,030,205 |
| Other Non Cash Items | $8,647,528 | $7,151,966 | $6,840,041 | $5,775,696 |
| Stock Based Compensation | $1,334,810 | $4,887,668 | $5,436,380 | $6,486,357 |
| Provisionand Write Offof Assets | $226,460 | $509,347 | $-109,862 | $-251,605 |
| Asset Impairment Charge | $6,136,864 | $89,947,762 | $2,532,068 | $4,181,946 |
| Deferred Tax | $-268,070 | $-2,419,661 | $-5,016,389 | $-3,712,413 |
| Deferred Income Tax | $-268,070 | $-2,419,661 | $-5,016,389 | $-3,712,413 |
| Depreciation Amortization Depletion | $8,563,260 | $6,872,820 | $6,898,565 | $7,047,642 |
| Depreciation And Amortization | $8,563,260 | $6,872,820 | $6,898,565 | $7,047,642 |
| Earnings Losses From Equity Investments | $736,106 | $1,632,216 | $2,433,282 | $2,577,869 |
| Gain Loss On Investment Securities | $-6,137 | $-318,810 | $-499,020 | $7,334 |
| Net Foreign Currency Exchange Gain Loss | $-890,273 | $-16,764 | $99,085 | $73,641 |
| Gain Loss On Sale Of PPE | $609,031 | $927,243 | $20,356 | $748 |
| Gain Loss On Sale Of Business | $0 | $0 | $-822,769 | $0 |
| Net Income From Continuing Operations | $-36,955,740 | $-87,887,024 | $3,883,193 | $-9,894,628 |
| Purchase Of Business | - | $0 | $0 | $-14,592,208 |
| Amortization Cash Flow | - | - | $3,794,136 | $3,807,457 |
| Amortization Of Intangibles | - | - | $3,794,136 | $3,807,457 |
| Depreciation | - | - | $3,104,429 | $3,240,185 |
Fetched: 2026-10-19